The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 64.00
Ask: 66.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.125%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 65.00
MYX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

15 Jan 2015 17:39

RNS Number : 3238C
MyCelx Technologies Corporation
15 January 2015
 

Not for release, publication or distribution directly or indirectly, in whole or in part, in or into or from the United States of America, its territories and possessions, any state of the United States, and the District of Columbia (collectively, the "United States"), Canada, Australia, the Republic of South Africa, the Republic of Ireland or Japan or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.

 

This press release does not constitute or form a part of, and should not be construed as, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities in MYCELX Technologies Corporation ("MYCELX" or the "Company").

 

THE COMPANY'S COMMON SHARES HAVE NOT BEEN REGISTERED UNDER THE US SECURITIES ACT OF 1933, AS AMENDED (THE "US SECURITIES ACT") OR ANY STATE SECURITIES LAWS (THE "STATE ACTS") AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO OR FOR THE ACCOUNT OR BENEFIT OF US PERSONS UNLESS THE SECURITIES ARE REGISTERED UNDER THE US SECURITIES ACT AND ANY APPLICABLE STATE ACTS, OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE US SECURITIES ACT AND ANY APPLICABLE STATE ACTS IS AVAILABLE. HEDGING TRANSACTIONS INVOLVING THE COMPANY'S COMMON SHARES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE US SECURITIES ACT.

 

 

MYCELX Technologies Corporation

 

("MYCELX" or the "Company") (AIM: MYX)

 

15 January 2015

 

2014 Year End Trading Update & Contract Wins

 

MYCELX Technologies Corporation (AIM: MYX), the clean water technology company providing patented solutions for commercial industrial markets worldwide, announces a trading update ahead of its 2014 Full Year Results, which will be announced on 20 March 2015.

 

The Company now expects to report full year revenue of $13.6 million for FY2014. This reduction in revenue results in a pre-tax loss of $5.7 million and an EBITDA of negative $4.2 million.

 

The Company had expected $1.8 million of revenue from an existing client on a stored waste water

project (lease, service and media). This contract has been delayed to coincide with operational maintenance expected in Q1 2015. An additional $450K of media revenue which was expected from a waste water project with a separate customer in December was not realized as the project was completed ahead of schedule due to lower than expected water volumes. The majority of the remaining shortfall resulted from end of year media sales forecasted from existing customers that did not occur.

 

Historically, the month of December has always been a strong one for revenue in the context of the Company's respective calendar year with clients spending surplus budgets for the year. This year we anticipated a similar trend. However, following our post year end analysis we believe that clients were reluctant to spend surplus budgets in response to the significant price declines in WTI and Brent prices in the last quarter of 2014. Such material moves in commodity prices, in conjunction with the significant sizes of certain contracts we are working on, makes forecasting extremely challenging.

 

 In reference to the three major projects that the Company has stated that it expects to execute in 2015, the Company has been awarded the contract for the short term waste water project. This is currently capped at $2.9 million. The Company is in discussions relating to the two larger projects and they remain active prospects. However, given the scale of the individual projects and the unpredictability of the timing of the project awards, the revenue forecast related to these projects has been revised downward for 2015. The Company has also received a $3.6 million contract for a lease renewal with one of its major customers in the Middle East.

 

The Company believes that given the uncertainty and extreme volatility surrounding the oil and gas industry it is not prudent to maintain its present revenue forecast for 2015. Therefore, the Company is revising its 2015 revenue to a range of $24 million to $29 million. Close attention and oversight of expenses is in place to assist EBITDA profitability at the lower end of the range.

 

Connie Mixon, CEO, commented:

 

"MYCELX will continue to provide long term value to the oil and gas industry. Cost effectively treating water associated with production and process will remain an important focus even in the difficult environment of volatile oil prices. The Company believes it should be profitable in 2015 by closely managing costs in line with revenue realized throughout the year and will continue to build its business for the future."

 

 

For further information please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Mark Clark, CFO

+1 888 306 6843

 

Numis Securities Limited

Corporate Finance 

Stuart Skinner

Nathaniel Janks

+44 20 7260 1000

 

Corporate Broking

James Black

Ben Stoop

+44 20 7260 1000

Bell Pottinger

Nick Lambert

Henry Lerwill

+44 20 3772 2500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKPDNOBKDFDD
Date   Source Headline
15th Mar 20197:00 amRNSHolding(s) in Company
13th Mar 20197:00 amRNSIssue of Equity
28th Feb 20194:54 pmRNSResults of Fundraising
28th Feb 20197:00 amRNSProposed $1.8 million Placing
13th Feb 201910:22 amRNSTrading Update
21st Dec 20187:00 amRNSHolding(s) in Company
11th Dec 20187:15 amRNSDirectorate Changes
7th Dec 20187:00 amRNSBlock Admission Interim Update
29th Nov 20187:00 amRNSNew Project Award and Trading Update
8th Oct 20187:00 amRNSNew Project Award and Trading Update
12th Sep 20187:00 amRNSHalf Year Results Statement
27th Jul 20187:00 amRNSContract Extension in Saudi Arabia
11th Jul 20181:16 pmRNSResult of Annual Meeting
7th Jun 20184:23 pmRNSBlock listing Interim Review
7th Jun 20183:42 pmRNSAnnual Financial Report
15th May 20187:00 amRNSFinal Results for the year ending 31 December 2017
19th Apr 20187:00 amRNSNew Purchase Order Award and Equipment Sale
13th Apr 201810:18 amRNSIssue of Equity
10th Apr 20187:00 amRNSPurchase Order Award & General Manager Appointment
28th Mar 201812:48 pmRNSHolding(s) in Company
16th Feb 20187:00 amRNSIssue of Equity
6th Feb 20187:00 amRNSExtension of Contract and New Project
17th Jan 20187:00 amRNSTrading Update
7th Dec 20179:46 amRNSBlock listing Interim Review
3rd Nov 201712:39 pmRNSIssue of Equity
26th Oct 20177:30 amRNSHolding(s) in Company
9th Oct 20177:00 amRNSIssue of Equity
27th Sep 20172:44 pmRNSApplication for Block Admission
26th Sep 20175:31 pmRNSClosure of Restricted Stock Line
21st Sep 20177:00 amRNSConsolidation of Stock Lines
13th Sep 20177:00 amRNSHalf Year Results Statement
12th Jul 201712:30 pmRNSResult of Annual Meeting
7th Jul 20177:00 amRNSHalf Year Trading Update
9th Jun 201710:00 amRNSMailing of Annual Financial Report & GM Notice
7th Jun 201710:30 amRNSBlock listing Interim Review
30th May 20171:19 pmRNSDirector/PDMR Shareholding
26th May 20177:00 amRNSContract win with new SABIC affiliate customer
11th May 20177:00 amRNSFinal Results for the year ending 31 December 2016
8th May 20177:00 amRNSContract Award & Notification of Full Year Results
30th Jan 20177:00 amRNSTrading Update
7th Dec 20162:34 pmRNSBlock listing Interim Review
4th Oct 20167:00 amRNSAppointment of Nominated Adviser & Broker
14th Sep 20167:00 amRNSHalf Year Results Statement
13th Jul 20164:21 pmRNSResult of AGM
11th Jul 20167:00 amRNSHalf Year Trading Update
30th Jun 20167:00 amRNSHolding(s) in Company
24th Jun 20167:00 amRNSMyCelx and Schlumberger Sign Upstream Agreement
9th Jun 20167:00 amRNSMailing of 2015 Annual Report and Notice of AGM
7th Jun 20163:32 pmRNSBlock listing Interim Review
17th May 20167:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.